Why is Symbiox Investme falling/rising?

As of 18-Jul, Symbiox Investment & Trading Co Ltd is experiencing a decline in its stock price, currently at 2.70, reflecting a decrease of 0.06 or 2.17%. The stock has underperformed its sector by 1.88% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a slight increase of 0.37%, but it has significantly underperformed over the last month with a decline of 14.56%. The company's return on equity stands at 0.6, and it is trading at a discount compared to its peers, yet it has reported operating losses and a weak long-term fundamental strength, which contributes to its negative performance.
Broader Market Context: The benchmark, represented by the Sensex, has shown a slight decline of 0.90% over the past week, while Symbiox's performance has been notably worse in the same timeframe. The stock has consistently underperformed against the benchmark over the last three years, with a year-to-date decline of 50.18% compared to the Sensex's gain of 4.63%. This consistent underperformance, coupled with falling investor participation—evidenced by a 49.74% drop in delivery volume—indicates a lack of confidence among investors, further exacerbating the stock's downward trend.